Prelude Therapeutics Growth Metrics (2024-2026) | PRLD

Growth Metrics Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) -36.79%-42.83%-48.76%-51.95%-19.49%-15.30%
Assets (QoQ) (Quarter) -11.01%-9.23%-12.07%-11.01%-19.52%-18.65%-17.55%49.14%-15.34%
Capital Expenditures Growth (1y) (Quarter) -83.74%-94.43%
Capital Expenditures (QoQ) (Quarter) 24.22%-82.45%-1,212.70%106.70%-57.45%
Cash & Equivalents Growth (1y) (Quarter) -43.69%54.13%142.53%234.48%113.44%91.37%
Cash & Equivalents (QoQ) (Quarter) -1.99%10.86%-52.38%8.83%168.27%74.44%-34.32%-30.55%140.53%
Cash from Investing Activities Growth (1y) (Quarter) 99.18%-55.89%273.53%-372.80%-86.33%
Cash from Investing Activities (QoQ) (Quarter) -16.34%-58.91%106.07%181.16%-81.47%247.98%-250.51%114.09%
Cash from Operations Growth (1y) (Quarter) -7.68%-13.09%29.97%211.45%36.65%
Cash from Operations (QoQ) (Quarter) 27.47%-18.38%24.00%-65.02%23.83%26.69%220.95%-193.80%
EBITDA Margin Growth (1y) (Quarter) 75,705.0042,989.00
EBITDA Margin (QoQ) (Quarter) 33,889.001,173.006,387.00
EBIT Growth (1y) (Quarter) -0.77%13.37%40.60%48.72%59.03%
EBIT Margin Growth (1y) (Quarter) 83,174.0053,819.00
EBIT Margin (QoQ) (Quarter) 30,009.00653.00-195.00
EBIT (QoQ) (Quarter) -8.21%7.50%1.59%-2.29%6.97%36.58%15.04%18.28%
EBT Growth (1y) (Quarter) -0.77%13.37%40.60%48.72%59.03%
EBT Margin Growth (1y) (Quarter) 83,174.0053,819.00
EBT Margin (QoQ) (Quarter) 30,009.00653.00-195.00
EBT (QoQ) (Quarter) -8.21%7.50%1.59%-2.29%6.97%36.58%15.04%18.28%
Enterprise Value Growth (1y) (Quarter) 41.91%49.93%32.15%63.09%25.02%-40.23%
Enterprise Value (QoQ) (Quarter) 13.09%10.72%14.26%12.69%25.09%-20.99%53.36%-77.37%-40.10%
EPS (Basic) Growth (1y) (Quarter) 0.00%10.87%39.53%47.37%69.05%
EPS (Basic) (QoQ) (Quarter) -9.52%6.52%11.63%-10.53%2.38%36.59%23.08%35.00%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) 0.00%10.87%39.53%47.37%69.05%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) -9.52%6.52%11.63%-10.53%2.38%36.59%23.08%35.00%
FCF Margin Growth (1y) (Quarter) 61,789.0091,099.00
FCF Margin (QoQ) (Quarter) 41,089.0070,399.00-88338.00
Free Cash Flow Growth (1y) (Quarter) -6.85%-11.44%30.13%215.35%36.74%
Free Cash Flow (QoQ) (Quarter) 27.01%-16.84%26.74%-71.02%23.87%26.75%220.95%-193.80%
Net Cash Flow Growth (1y) (Quarter) 4,859.42%-565.14%225.62%-1,016.12%-148.57%
Net Cash Flow (QoQ) (Quarter) 634.42%-634.89%108.03%1,974.25%-152.23%244.46%-158.54%-9.97%
Net Income Growth (1y) (Quarter) -0.77%13.37%40.60%48.72%59.03%
Net Income (QoQ) (Quarter) -8.21%7.50%1.59%-2.29%6.97%36.58%15.04%18.28%
Net Income towards Common Stockholders Growth (1y) (Quarter) -0.77%13.37%40.60%48.72%59.03%
Net Income towards Common Stockholders (QoQ) (Quarter) -8.21%7.50%1.59%-2.29%6.97%36.58%15.04%18.28%
Net Margin Growth (1y) (Quarter) 83,174.0053,819.00
Net Margin (QoQ) (Quarter) 30,009.00653.00-195.00
Operating Income Growth (1y) (Quarter) -0.77%13.37%40.60%48.72%59.03%
Operating Income (QoQ) (Quarter) -8.21%7.50%1.59%-2.29%6.97%36.58%15.04%18.28%
Operating Margin Growth (1y) (Quarter) 83,174.0053,819.00
Operating Margin (QoQ) (Quarter) 30,009.00653.00-195.00
Profit After Tax Growth (1y) (Quarter) -2.08%10.10%38.88%42.72%67.63%
Profit After Tax (QoQ) (Quarter) -10.53%7.11%10.97%-11.67%2.66%36.84%16.57%36.90%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) -7.62%-12.42%-21.15%-23.20%-24.44%-26.08%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -0.42%3.56%-4.66%-6.04%-5.60%-6.76%-7.14%-7.56%-7.65%
Return on Assets Growth (1y) (Quarter) -1.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -7384.00620.00
Return on Capital Employed (QoQ) (Quarter) -1407.00-2497.00-1374.00-2106.006,598.00
Return on Equity Growth (1y) (Quarter) -1.00-1.000.00
Return on Equity (QoQ) (Quarter) 0.000.000.000.000.000.00
Return on Sales Growth (1y) (Quarter) 8.005.00
Return on Sales (QoQ) (Quarter) 3.000.000.00
Revenue Growth (1y) (Quarter) 116.67%41.00%
Revenue (QoQ) (Quarter) 33.33%-13.23%-18.79%
Share-based Compensation Growth (1y) (Quarter) -30.92%-37.45%-59.11%-51.14%-47.81%
Share-based Compensation (QoQ) (Quarter) 9.93%-2.82%-36.31%1.54%-0.47%-36.47%-23.90%8.46%
Shareholder's Equity Growth (1y) (Quarter) -44.55%-51.04%-58.39%-62.58%-47.79%-41.67%
Shareholder's Equity (QoQ) (Quarter) -11.12%-13.50%-14.18%-15.96%-21.51%-26.50%-22.82%17.26%-12.32%